Loading organizations...
Loading organizations...
Biotechnology company developing cancer therapeutics for solid tumors.
Tyrogenex has raised $15.0M across 1 funding round.
Tyrogenex has raised $15.0M in total across 1 funding round.
Tyrogenex has raised $15.0M in total across 1 funding round.
Tyrogenex's investors include Vinzenz Ploerer.
Tyrogenex has raised $15.0M across 1 funding round. Most recently, it raised $15.0M Series D in June 2014.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 19, 2014 | $15.0M Series D | Vinzenz Ploerer |